One Biosciences utilizes single-cell technologies and AI-driven analysis to create high-resolution omics profiles of tumors, enabling precise patient selection and treatment strategies. This approach addresses the complexity of advanced cancer biology, facilitating the development of targeted therapeutics for difficult-to-treat diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Advanced cancers exhibit complex and poorly understood biology, making it difficult to select the right patients for targeted therapies. Current molecular profiling approaches often lack the resolution needed to fully characterize tumor heterogeneity and predict treatment response. This complexity hinders the development of effective therapies for difficult-to-treat diseases.
Solution
One Biosciences leverages single-cell technologies and AI-driven analysis to create high-resolution omics profiles of tumors. Their approach provides a functional profile of a patient's tumor at a specific point in time, deconvoluting the complex biology often present in advanced cancer. By applying cutting-edge single-cell technologies and AI, One Biosciences enables precise patient selection, facilitates the development of novel therapies, optimizes treatment strategies, and improves clinical trial matching. Their solutions, OneMap™ and OneCure™, drive the development of novel molecular profiling approaches in clinical practice and de-risk/rescue clinical development through better patient population selection or biomarker strategy.
Target Audience
The primary target audience includes pharmaceutical companies, research institutions, and clinicians involved in cancer research, drug development, and precision medicine.
Features
- Single-cell based proprietary technology for high-resolution omics profiling
- AI-driven analysis to deconvolute complex cancer biology
- OneMap™ solution for driving novel molecular profiling approaches in clinical practice
- OneCure™ solution for developing novel therapies through improved patient selection and biomarker strategy
- Identification of optimal treatment strategies based on tumor profiling
- Clinical trial matching based on high-resolution omics data